Flexpa
Flexpa provides a sandbox environment for developers to test applications using synthetic patients and offers a single integration gateway for accessing comprehensive patient health data in the U.S.
Services
Flexpa offers a comprehensive suite of services designed to simplify the integration and access to patient health data for developers and healthcare organizations. Key services include a sandbox environment for developers to test applications using payer-provided synthetic patients, a single integration gateway to access electronic claims data, and a secure environment for ingesting various patient data. Flexpa supports patient-consented access to sensitive information such as demographic info, medical expenses, allergy records, and more. The company provides unlimited FHIR API calls and test mode access, catering to clients ranging from startups to large enterprises.
Products
Flexpa's primary product offering, Flexpa Link, serves as a tool for enabling single integration to access patients' health data. This product facilitates the ingestion of a wide array of patient data from demographics to detailed medical histories securely within seconds. Flexpa offers pricing plans including a Basic package starting at $2 per patient link and an Enterprise package at $2.50 per patient link. Additionally, the sandbox environment allows developers to test applications with payer-provided synthetic patients, supporting development and testing across over 200 payers.
Founders
Flexpa was originally founded as Automate Medical and publicly announced in March 2020. The company's initial mission focused on interpreting pulmonary function tests before shifting to developing tools for the FHIR (Fast Healthcare Interoperability Resources) community. With a strong belief in flexible patient access to health information and claims data, the founders steered the company towards its current focus, enabling secure and efficient access to diverse patient health data.
History
Flexpa was founded as Automate Medical in March 2020. Initially, the company aimed to interpret pulmonary function tests. However, recognizing the potential within health data integration, the company pivoted to develop tools for the FHIR community. Supported by a consortium of investors including General Catalyst, Apollo Projects, and a16z, Flexpa has evolved to facilitate secure, patient-consented access to comprehensive health and claims data, streamlining application development for healthcare providers and developers alike.
Investors
Flexpa is backed by a diverse group of investors showing strong confidence in the company's mission and potential. Notable supporters include General Catalyst, Apollo Projects, Greycroft, a16z, Village Global, Blitzscaling Ventures, Tusk Ventures, and Tribe Capital. These investors bring a wealth of experience and resources to Flexpa, helping to accelerate its growth and expand its capabilities in facilitating secure and efficient access to patient health data.